Identification of circulating plasma ceramides as a potential sexually dimorphic biomarker of pancreatic cancer‐induced cachexia

Identification of circulating plasma ceramides as a potential sexually dimorphic biomarker of pancreatic cancer‐induced cachexia

Abstract Background Cancer patients who exhibit cachexia lose weight and have low treatment tolerance and poor outcomes compared with cancer patients without weight loss. Despite the clear increased risk for patients, diagnosing cachexia still often relies on self‐reported weight loss. A reliable bi...

Full description

Bibliographic Details
Main Authors: Jeffery M. Chakedis, Mary E. Dillhoff, Carl R. Schmidt, Priyani V. Rajasekera, David C. Evans, Terence M. Williams, Denis C. Guttridge, Erin E. Talbert
Format: Article
Language:English
Published: Wiley 2022-07-01
Series:JCSM Rapid Communications
Subjects:
Biomarker
Cachexia
Cancer
Ceramide
Pancreatic ductal adenocarcinoma
Sexual dimorphism
Online Access:https://doi.org/10.1002/rco2.68

Internet

https://doi.org/10.1002/rco2.68

Similar Items